Ramesh Swaminathan, Global CFO of pharmaceutical company Lupin, warns that Trump tariffs could deny many in the U.S. access ...

Launch details are bound by confidentiality. Lupin Pharmaceuticals, Inc., which was its partner for the abbreviated new drug application approved by the U.S. FDA, will be marketing the product in ...

Lupin has received tentative approval from the Food and Drug Administration for darunavir, cobicistat, emtricitabine, and ...

Lupin's shares recovered after strong Q3 FY25 results, with a net profit of ₹858.9 crore, up 38.8%. North America sales grew ...

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. One of the most-watched shows on Netflix right now is the true definition of a surprise ...

19:50 EST Tonix Pharmaceuticals (TNXP) trading halted, news pending Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed ...

Oppenheimer initiated coverage of ARS Pharmaceuticals (SPRY) with an Outperform rating and $40 price target As the first and only approved needle-free epinephrine product, neffy has the potential ...

NORTHFIELD, Minn., Feb. 4, 2025 /PRNewswire/ -- Aurora Pharmaceutical, a leader in animal health solutions, is proud to announce a 30% expansion of its sales force over the past three years.

Gland Pharma reported a 6.7% rise in net profit, reaching Rs 204.7 crore. However, revenue declined by 10.4%, dropping to Rs 1,384 crore from Rs 1,545.2 crore last year. Textile company Bombay ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration (FDA). The company’s "first-in-class" suzetrigine pain pill ...

Stocks like GR Infraprojects,Anant Raj, Aarti Industries, Gujarat Gas, MOIL, Coal India, Indian Bank, Quess Corp, and HM Electro Mech will be in focus on February 3.

Is Lupin getting a season four, or is the recent third season going to be the show's last on Netflix? We're sorry to say that there's not been any recent updates ...